*Contraindications weight loss injections include a personal or family history of medullary thyroid cancer, allergy to GLP-1 and weight loss injections, Type 1 Diabetes or history of Diabetic Ketoacidosis, personal or family history of Multiple Endocrine Neoplasia, personal history of Pancreatitis, renal impairment or kidney disease, gallbladder disease, or concurrent use of anti-diabetic medications or insulin
If your semaglutide arrives warm to the touch or has been exposed to temperatures outside the recommended range, do not use the medication immediately
Studies suggest these foods may increase digestive discomfort for some individuals taking tirzepatide
Remaining Challenges in ePA for GLP-1s While ePA greatly reduces friction, some challenges remain: Incomplete Payer Connectivity: Not every insurer will accept ePA for every drug/plan
We do not accept responsibility for delays to packages, any additional charges relating to customs fees and duties